Neurosoft Bioelectronics
- Company typePrivate
- Founded2015
- HeadquartersGeneva, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Neurosoft Bioelectronics firmographics
Firmographics- Name
- Neurosoft Bioelectronics
- Legal name
- Neurosoft Bioelectronics SA
- Website
- https://neurosoft-bio.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Neurosoft Bioelectronics industry classification
Industry- Product category
- Neurotechnology / Brain-Computer Interface Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)
- akta.pro secondary industries
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE), Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)
Keywords
Where Neurosoft Bioelectronics is headquartered
LocationHeadquarters
- HQ city
- Geneva
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Neurosoft Bioelectronics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales
Revenue model
- Brain-Computer Interface Medical Devices: Pre-commercial stage. The company is developing implantable BCI systems for treating neurological conditions including epilepsy, tinnitus, and motor disorders. Revenue expected from device sales and related medical services upon regulatory approval.
- Clinical Trial Services: Providing BCI technology for clinical research conducted at partner institutions including UTHealth Houston and UMC Utrecht.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Neurosoft Bioelectronics product offering
Product offeringCore offering
Neurosoft Bioelectronics develops and manufactures soft, minimally invasive brain-computer interface (BCI) medical devices for monitoring and treating neurological disorders including epilepsy, severe tinnitus, and motor disabilities. The company's proprietary technology platform produces soft electrodes that are 1,000 to 100,000 times softer than alternatives, enabling minimally invasive implantation through burr holes and integration with AI for biomarker detection and neural decoding.
Product overview
Neurosoft Bioelectronics develops a portfolio of soft, stretchable brain-computer interface products built on its proprietary technology platform. The core platform provides soft electrodes that are 1,000 to 100,000 times softer than alternatives. Key products include SOFT ECoG™ (subdural electrode arrays for sub-chronic brain recording/stimulation up to 30 days), MINDZ™ (minimally invasive implantable brain interface deployed via burr hole), SOFT TINNIT™ (fully implantable closed-loop system for severe tinnitus treatment), and Synapsuit (BCI-controlled soft wearable exosuit for upper-limb motor disabilities). The company integrates AI throughout its platform for biomarker detection, neuromodulation optimization, and motor/speech decoding.
Differentiator
Problem solved
Functional benefit
Brands
- SOFT ECoG™: A family of subdural electrodes for brain signal recording or stimulation intra-operatively or for up to 30 days, built on the soft brain interface technology platform.
- MINDZ™
- SOFT TINNIT™
- Synapsuit
Products and services
- Soft Brain Interface Technology Platform Proprietary soft, elastic brain interface technology platform with electrodes that are 1,000 to 100,000 times softer and 3-5 times thinner than alternative solutions, providing enhanced bio-integration and minimized mechanical mismatch with neural tissues. The platform reduces scar tissue formation, subdural hematomas, and brain compression risks while enabling minimally invasive implantation through burr holes.
- SOFT ECoG™ Subdural electrode arrays for brain signal recording or stimulation intended for intra-operative use or up to 30 days of sub-chronic use. Used for identifying epileptogenic brain tissue in drug-resistant epilepsy patients and for brain mapping/monitoring during resection surgeries.
- MINDZ™ Minimally invasive brain interface implantable on the brain surface using a deployment system that leverages soft mechanical properties allowing folding/unfolding without damage. First application supports localization of epileptic foci for drug-resistant epilepsy patients through burr hole insertion.
- SOFT TINNIT™ Fully implantable closed-loop brain-computer interface system specifically designed to treat severe tinnitus by uniquely targeting and neuromodulating specific areas of the brain to suppress or significantly reduce perceived ringing. Based on neurofeedback approach that achieved 130% better outcomes compared to CBT in clinical studies.
- Synapsuit Brain-computer interface system with AI algorithm to decode brain signals and control a lightweight soft wearable exosuit for supporting arm and hand movements in real time for patients with severe upper-limb motor disabilities. Developed in collaboration with Wyss Center, Korea Electronics Technology Institute, and Jang EUN FnC.
Quantifiable outcome
- 130% better outcome compared to CBT for tinnitus treatment in clinical study
- +2 more outcomes
Companies that use Neurosoft Bioelectronics
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Neurosoft Bioelectronics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature7 records
Neurosoft Bioelectronics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered infrastructure, core, major and project.
- CSCS (Swiss National Supercomputing Centre)infrastructureAwarded computational access to Alps supercomputer (ranked 8th globally) to train neural decoding models using proprietary soft electrode technology.
- Science CorporationcoreMultiyear, multimillion-dollar partnership granting Neurosoft access to Science's full stack of clinical-grade neural recording tools within the Science BCI Ecosystem. This collaboration reduces BCI development costs from $75-100 million to under $5 million for first-in-human trials. Neurosoft develops implantable BCI systems for treating tinnitus, epilepsy, and other neurological disorders. Neurosoft is the inaugural inductee into Science Corp's academic access program.
- Wyss CentermajorCollaboration on Synapsuit project for BCI-controlled exosuit technology for upper limb motor disabilities.
- Korea Electronics Technology InstituteprojectCollaboration on Synapsuit project for soft wearable exosuit technology.
- Jang EUN FnCprojectCollaboration on Synapsuit project for BCI-controlled exosuit technology.
Scale indicators6 records
Recent moves6 records
Expansion highlights7 records
Neurosoft Bioelectronics competitors and assessment
Company assessmentDirect peers
- Synchron: Synchron is a direct competitor developing implantable brain-computer interfaces (Stentrode) targeting motor restoration in paralysis. Both are clinical-stage BCI companies pursuing implantable neural interfaces, with Synchron further along in human trials.
- Blackrock Neurotech: Blackrock Neurotech is a direct peer in implantable BCIs using Utah Array-style electrode systems for motor and speech restoration. They have the largest implanted BCI patient base, providing the most direct comparable for Neurosoft's clinical and regulatory path.
- Paradromics: Paradromics is a direct BCI peer building high-data-rate implantable neural interfaces for speech and motor restoration. Both companies are clinical-stage with comparable funding scale and a focus on minimally invasive neural recording.
- Precision Neuroscience: Precision Neuroscience is a direct peer developing a high-electrode-count cortical interface (Layer 7) for clinical and BCI applications. Both companies compete for FDA pathways in implantable cortical recording and share the neuromodulation/neuro-monitoring overlap with Neurosoft's SOFT ECoG.
- CorTec: CorTec is a German company developing implantable brain-computer interfaces and electrode technology for research and clinical applications. Both companies serve the implantable neuro-interface market with a focus on long-term, biocompatible neural recording and stimulation.
- MicroProbes for Life Science & Research: MicroProbes manufactures microelectrodes and neural recording/stimulation arrays used in preclinical neuroscience and BCI research. Both companies supply electrode-based neural interface technology for clinical and research applications, with overlapping customer profiles in academic medical centers.
Broad incumbents
- Neuralink: Neuralink is the highest-profile implantable BCI company developing high-bandwidth neural interfaces. As a much larger, well-capitalized player with its own FDA-approved human trial, it defines the competitive backdrop for Neurosoft's clinical and commercial strategy.
- Neuronetics: Neuronetics is a publicly listed neuromodulation company commercializing transcranial magnetic stimulation (NeuroStar) for depression. While non-invasive, it is a relevant comparable for the clinical/commercial pathway Neurosoft will face with SOFT TINNIT in neurology indications.
Emerging players
- Inbrain Neuroelectronics: Inbrain Neuroelectronics is an emerging BCI peer developing graphene-based neural interfaces for neuromodulation in Parkinson's and epilepsy. It overlaps with Neurosoft's MINDZ/SOFT ECoG epilepsy applications and shares a similar European clinical-stage profile.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks2 records
Key highlights7 records
Customer concentration
Neurosoft Bioelectronics social profiles
Digital presenceNeurosoft Bioelectronics compliance and trust
Trust signalCompliance1 record
Neurosoft Bioelectronics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neurosoft Bioelectronics leadership team
Management profileNumber of profiles
Profiles17 records
Neurosoft Bioelectronics funding detail
Funding detailFunding overview
Funding rounds10 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neurosoft Bioelectronics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neurosoft Bioelectronics
What does Neurosoft Bioelectronics do?
Neurosoft Bioelectronics develops and manufactures soft, minimally invasive brain-computer interface (BCI) medical devices for monitoring and treating neurological disorders including epilepsy, severe tinnitus, and motor disabilities. The company's proprietary technology platform produces soft electrodes that are 1,000 to 100,000 times softer than alternatives, enabling minimally invasive implantation through burr holes and integration with AI for biomarker detection and neural decoding.
Is Neurosoft Bioelectronics a public or private company?
Neurosoft Bioelectronics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Neurosoft Bioelectronics founded?
Neurosoft Bioelectronics was founded in 2015. It employs 11 to 50 people.
Where is Neurosoft Bioelectronics based?
Neurosoft Bioelectronics is headquartered in Geneva, Switzerland, in the Europe region.
How does Neurosoft Bioelectronics make money?
Two revenue lines are on record. Brain-Computer Interface Medical Devices are the primary driver. The others are clinical Trial Services.
Who are Neurosoft Bioelectronics's main competitors?
Direct peers on record are Synchron, Blackrock Neurotech, Paradromics, Precision Neuroscience, CorTec and MicroProbes for Life Science & Research. Broad incumbents are Neuralink and Neuronetics. Inbrain Neuroelectronics is listed as an emerging player.
Does Neurosoft Bioelectronics have an API?
No public API is recorded for Neurosoft Bioelectronics.
What industry is Neurosoft Bioelectronics in?
Neurosoft Bioelectronics's product category is Neurotechnology / Brain-Computer Interface Medical Devices. Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS), with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 334510 and its SIC code is 3845.